Amanote Research
Register
Sign In
Intrinsa Fails to Impress FDA Advisory Panel
International Journal of Impotence Research
- United Kingdom
doi 10.1038/sj.ijir.3901308
Full Text
Open PDF
Abstract
Available in
full text
Categories
Urology
Date
March 17, 2005
Authors
R F Spark
Publisher
Springer Science and Business Media LLC
Related search
Secret-Public Voting in FDA Advisory Committees
FDA Panel Backs Interleukin-2
Nature
Multidisciplinary
Shaving to Impress
Nature
Multidisciplinary
Minority Affairs Advisory Panel Reviews ACS Programs
Chemical and Engineering News
Chemical Engineering
From the FDA: New Class of Asthma Drug Receives Advisory Approval
Journal of the American Osteopathic Association, The
Medicine
Alternative Medicine
Complementary
DoD Historical Records Declassification Advisory Panel, (Fifth Session),
From the FDA: Panel Recommends Approval of Drug for ALS
Journal of the American Osteopathic Association, The
Medicine
Alternative Medicine
Complementary
Commentary on Androgen Deficiency in Women and the FDA Advisory Board's Recent Decision to Request More Safety Data
International Journal of Impotence Research
Urology
Using IMPrESS to Guide Policy Change in Multiple Sclerosis
Multiple Sclerosis
Neurology
